365betÌåÓýÔÚÏßÊÀ½ç±­

Skip to main content
You have permission to edit this article.
Edit
Alert Top Story

'De-extinction' startup with $10 billion valuation revives dire wolf

Bioscience

Ben Lamm, Andrew Pask and George Church of Colossal Biosciences. Colossal Biosciences has announced plans to bring back the thylacine, more commonly known as the Tasmanian tiger. 

Colossal Biosciences Inc., a Dallas-based biotech firm with a $10 billion valuation, has announced a new breakthrough in its audacious mission to resurrect extinct animals.

The company said on Monday it’s created three dire wolves, a species popularized by the fantasy series "Game of Thrones" but not seen on Earth in more than 12,000 years.





Explore More

Alert Top Story

“To us, it’s so obvious the impact that can be made just in a short amount of time and with a small budget,� said Amy Eschbach, a nurse who has worked with CAPABLE clients in the St. Louis area, where a Medicare Advantage plan covers CAPABLE. Read moreHome improvements can help people age independently. But Medicare seldom picks up the bill

Get up-to-the-minute news sent straight to your device.

Topics

News Alerts

Breaking News

Breaking News (FlagLive!)